These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 9815934

  • 1. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F.
    Clin Cancer Res; 1995 Nov; 1(11):1375-83. PubMed ID: 9815934
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of clinical parameters and biological markers in patients with squamous cell carcinoma of the head and neck treated with concurrent chemoradiotherapy.
    Homma A, Furuta Y, Oridate N, Nakano Y, Kohashi G, Yagi K, Nagahashi T, Yagi K, Nagahashi T, Fukuda S, Inoue K, Inuyama Y.
    Clin Cancer Res; 1999 Apr; 5(4):801-6. PubMed ID: 10213215
    [Abstract] [Full Text] [Related]

  • 3. c-erbB-2 oncoprotein is overexpressed in poorly vascularised squamous cell carcinomas of the head and neck, but is not associated with response to cytotoxic therapy or survival.
    Giatromanolaki A, Koukourakis MI, Sivridis E, Fountzilas G.
    Anticancer Res; 2000 Apr; 20(2A):997-1004. PubMed ID: 10810387
    [Abstract] [Full Text] [Related]

  • 4. p53 and bcl-2 expression in locally advanced squamous cell head-neck cancer treated with platinum based chemotherapy and radiotherapy.
    Giatromanolaki A, Koukourakis M, Zaramboukas T, Skordalaki A, Arapantoni P, Georgoulias V, Fountzilas G.
    Anticancer Res; 1998 Apr; 18(6B):4685-92. PubMed ID: 9891541
    [Abstract] [Full Text] [Related]

  • 5. Tumour stage, node stage, p53 gene status, and bcl-2 protein expression as predictors of tumour response to platin-fluorouracil chemotherapy in patients with squamous-cell carcinoma of the head and neck.
    Fouret P, Temam S, Charlotte F, Lacau-St-Guily J.
    Br J Cancer; 2002 Dec 02; 87(12):1390-5. PubMed ID: 12454767
    [Abstract] [Full Text] [Related]

  • 6. Bilharzial related, organ confined, muscle invasive bladder cancer: prognostic value of apoptosis markers, proliferation markers, p53, E-cadherin, epidermal growth factor receptor and c-erbB-2.
    Haitel A, Posch B, El-Baz M, Mokhtar AA, Susani M, Ghoneim MA, Marberger M.
    J Urol; 2001 May 02; 165(5):1481-7. PubMed ID: 11342901
    [Abstract] [Full Text] [Related]

  • 7. Expression of bcl-2 protein predicts efficacy of adjuvant treatments in operable node-positive breast cancer.
    Gasparini G, Barbareschi M, Doglioni C, Palma PD, Mauri FA, Boracchi P, Bevilacqua P, Caffo O, Morelli L, Verderio P.
    Clin Cancer Res; 1995 Feb 02; 1(2):189-98. PubMed ID: 9815973
    [Abstract] [Full Text] [Related]

  • 8. Angiogenesis, thymidine phosphorylase, and resistance of squamous cell head and neck cancer to cytotoxic and radiation therapy.
    Koukourakis MI, Giatromanolaki A, Fountzilas G, Sivridis E, Gatter KC, Harris AL.
    Clin Cancer Res; 2000 Feb 02; 6(2):381-9. PubMed ID: 10690514
    [Abstract] [Full Text] [Related]

  • 9. Prognostic value of apoptosis-regulating protein expression in anal squamous cell carcinoma.
    Allal AS, Waelchli L, Bründler MA.
    Clin Cancer Res; 2003 Dec 15; 9(17):6489-96. PubMed ID: 14695153
    [Abstract] [Full Text] [Related]

  • 10. Necessity for adjuvant neck dissection in setting of concurrent chemoradiation for advanced head-and-neck cancer.
    Brizel DM, Prosnitz RG, Hunter S, Fisher SR, Clough RL, Downey MA, Scher RL.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1418-23. PubMed ID: 15050318
    [Abstract] [Full Text] [Related]

  • 11. Evidence for a dose-response effect between p53 (but not p21WAF1/Cip1) protein concentrations, survival, and responsiveness in patients with epithelial ovarian cancer treated with platinum-based chemotherapy.
    Levesque MA, Katsaros D, Massobrio M, Genta F, Yu H, Richiardi G, Fracchioli S, Durando A, Arisio R, Diamandis EP.
    Clin Cancer Res; 2000 Aug 01; 6(8):3260-70. PubMed ID: 10955812
    [Abstract] [Full Text] [Related]

  • 12. P53 and Ki-67 as outcome predictors for advanced squamous cell cancers of the head and neck treated with chemoradiotherapy.
    Lavertu P, Adelstein DJ, Myles J, Secic M.
    Laryngoscope; 2001 Nov 01; 111(11 Pt 1):1878-92. PubMed ID: 11801963
    [Abstract] [Full Text] [Related]

  • 13. Prognostic significance of bcl-2 expression in stage III breast cancer patients who had received doxorubicin and cyclophosphamide followed by paclitaxel as adjuvant chemotherapy.
    Lee KH, Im SA, Oh DY, Lee SH, Chie EK, Han W, Kim DW, Kim TY, Park IA, Noh DY, Heo DS, Ha SW, Bang YJ.
    BMC Cancer; 2007 Apr 12; 7():63. PubMed ID: 17430582
    [Abstract] [Full Text] [Related]

  • 14. Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
    Argiris A, Stenson KM, Brockstein BE, Mittal BB, Pelzer H, Kies MS, Jayaram P, Portugal L, Wenig BL, Rosen FR, Haraf DJ, Vokes EE.
    Head Neck; 2004 May 12; 26(5):447-55. PubMed ID: 15122662
    [Abstract] [Full Text] [Related]

  • 15. Predictors of response to chemo-radiotherapy and radiotherapy for esophageal squamous cell carcinoma.
    Miyazaki T, Kato H, Faried A, Sohda M, Nakajima M, Fukai Y, Masuda N, Manda R, Fukuchi M, Ojima H, Tsukada K, Kuwano H.
    Anticancer Res; 2005 May 12; 25(4):2749-55. PubMed ID: 16080521
    [Abstract] [Full Text] [Related]

  • 16. Prognostic significance of p53, bcl-2 and Ki-67 in high risk superficial bladder cancer.
    Stavropoulos NE, Filiadis I, Ioachim E, Hastazeris K, Tsimaris I, Kalogeras D, Stefanaki S, Agnantis NJ.
    Anticancer Res; 2002 May 12; 22(6B):3759-64. PubMed ID: 12552989
    [Abstract] [Full Text] [Related]

  • 17. Predictive value of p53 and 14-3-3sigma for the effect of chemoradiation therapy on esophageal squamous cell carcinoma.
    Okumura H, Natsugoe S, Matsumoto M, Yokomakura N, Uchikado Y, Takatori H, Ishigami S, Takao S, Aikou T.
    J Surg Oncol; 2005 Jul 01; 91(1):84-9. PubMed ID: 15999354
    [Abstract] [Full Text] [Related]

  • 18. [Multivariate analysis of the prognostic and predictive factors of response to concomitant radiochemotherapy in epidermoid cancers of the esophagus. Value of immunodetection of protein p53].
    Seitz JF, Perrier H, Monges G, Giovannini M, Gouvernet J.
    Gastroenterol Clin Biol; 1995 May 01; 19(5):465-74. PubMed ID: 7589997
    [Abstract] [Full Text] [Related]

  • 19. Esophagectomy after concurrent chemoradiotherapy improves locoregional control in clinical stage II or III esophageal cancer patients.
    Liao Z, Zhang Z, Jin J, Ajani JA, Swisher SG, Stevens CW, Ho L, Smythe R, Vaporciyan AA, Putnam JB, Walsh GL, Roth JA, Yao JC, Allen PK, Cox JD, Komaki R.
    Int J Radiat Oncol Biol Phys; 2004 Dec 01; 60(5):1484-93. PubMed ID: 15590179
    [Abstract] [Full Text] [Related]

  • 20. Expression of Bcl-2 family proteins in advanced laryngeal squamous cell carcinoma: correlation with response to chemotherapy and organ preservation.
    Trask DK, Wolf GT, Bradford CR, Fisher SG, Devaney K, Johnson M, Singleton T, Wicha M.
    Laryngoscope; 2002 Apr 01; 112(4):638-44. PubMed ID: 12150516
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.